Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.16B |
| 2 |
JPMorgan Chase
JPM
|
+$1.03B |
| 3 |
FedEx
FDX
|
+$857M |
| 4 |
Northrop Grumman
NOC
|
+$818M |
| 5 |
Humana
HUM
|
+$811M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.16B |
| 2 |
Intel
INTC
|
+$1.38B |
| 3 |
Bank of America
BAC
|
+$1.18B |
| 4 |
Verizon
VZ
|
+$1.07B |
| 5 |
Netflix
NFLX
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Technology | 18.46% |
| 3 | Financials | 11.78% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
TG Therapeutics
TGTX
$7.59B
| $88.5M | 0.02% |
+3,307,046
| New | +$76.1M |
|
552
Take-Two Interactive
TTWO
$43.5B
| $88.2M | 0.02% |
533,888
-53,131
| -9% | -$8.63M |
|
|
DRNA
553
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $88.1M | 0.02% |
4,896,153
+553,984
| +13% | +$11.5M |
|
554
Rockwell Automation
ROK
$49.2B
| $88M | 0.02% |
398,843
-368,781
| -48% | -$82.4M |
|
555
Diageo
DEO
$51.6B
| $87.3M | 0.02% |
633,875
+989
| +0.2% | +$136K |
|
556
Onto Innovation
ONTO
$13.4B
| $87M | 0.02% |
2,922,133
-943,108
| -24% | -$31.3M |
|
557
Healthcare Services Group
HCSG
$1.51B
| $86.9M | 0.02% |
4,037,977
-174,017
| -4% | -$4.06M |
|
|
AVLR
558
DELISTED
Avalara, Inc.
AVLR
| $86.2M | 0.02% |
676,854
-29,915
| -4% | -$3.8M |
|
|
AMWD
559
DELISTED
American Woodmark
AMWD
| $85.7M | 0.02% |
1,091,755
+69,694
| +7% | +$5.69M |
|
560
Spectrum Brands
SPB
$2.03B
| $85.4M | 0.02% |
1,493,479
-122,864
| -8% | -$6.74M |
|
561
CenterPoint Energy
CNP
$26.8B
| $85.2M | 0.02% |
4,405,582
+1,032,154
| +31% | +$20.3M |
|
562
Simply Good Foods
SMPL
$988M
| $85.1M | 0.02% |
3,861,303
+925,901
| +32% | +$21.5M |
|
563
NovoCure
NVCR
$1.83B
| $84.9M | 0.02% |
762,811
-1,006,718
| -57% | -$80.5M |
|
|
FOLD
564
DELISTED
Amicus Therapeutics
FOLD
| $84.8M | 0.02% |
6,003,155
-720,136
| -11% | -$10.5M |
|
565
Otis Worldwide
OTIS
$28.1B
| $84.4M | 0.02% |
1,351,992
-169,475
| -11% | -$10.4M |
|
566
CNO Financial Group
CNO
$5.14B
| $84.3M | 0.02% |
5,255,532
-1,122,831
| -18% | -$18M |
|
|
CATM
567
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $84.2M | 0.02% |
4,253,143
+454,170
| +12% | +$9.91M |
|
|
IMGN
568
DELISTED
Immunogen Inc
IMGN
| $83.1M | 0.02% |
23,080,128
-231,510
| -1% | -$935K |
|
|
DOC
569
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $82.1M | 0.02% |
4,583,897
-1,237,793
| -21% | -$22.1M |
|
|
CTB
570
DELISTED
Cooper Tire & Rubber Co.
CTB
| $81.3M | 0.02% |
2,565,295
+550,114
| +27% | +$17.9M |
|
571
SLM Corp
SLM
$5.15B
| $81.1M | 0.02% |
10,027,621
-1,381,626
| -12% | -$10.1M |
|
572
CSX Corp
CSX
$93.9B
| $80.9M | 0.02% |
3,123,021
-2,046,534
| -40% | -$50.5M |
|
|
CEO
573
DELISTED
CNOOC Limited
CEO
| $79.2M | 0.02% |
824,616
-19,956
| -2% | -$2.2M |
|
574
ITT
ITT
$19.2B
| $78.6M | 0.02% |
1,330,348
-30,320
| -2% | -$1.84M |
|
575
Itron
ITRI
$4.5B
| $78.5M | 0.02% |
1,292,137
-412,971
| -24% | -$26.3M |
|
Similar funds
Wellington Management Group's Q3 2020 Portfolio in Review
As of Q3 2020, Wellington Management Group held 2,048 positions worth $483B, up 7.6% from $449B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q3 2020 filing shows 214 new, 682 increased, 869 reduced and 176 closed positions. Its largest new stake was nCino: 7,715,323 shares worth $598M. The largest sale was Apple, an estimated $2.16B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q3 2020 buy was nCino: 7,715,323 shares worth $598M.
- Wellington Management Group added most to Procter & Gamble in Q3 2020, an estimated $1.16B increase.
- Wellington Management Group's biggest Q3 2020 reduction was Apple, cutting an estimated $2.16B.
- Wellington Management Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $160M.
- Wellington Management Group's ten largest holdings make up 18% of its $483B portfolio in Q3 2020.
- Wellington Management Group opened 214 new positions and closed 176 in Q3 2020.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $483B.
Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.